Quick Answer
Annovis Bio, Inc. reported Stockholders Equity of $16.85 million for fiscal year 2025.
Annovis Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $16.85M | +81.0% |
| 2024 | $9.31M | +220.1% |
| 2023 | -$7.75M | -127.4% |
| 2022 | $28.32M | -18.1% |
| 2022 | $34.59M | -10.5% |
| 2022 | $38.67M | -9.4% |
| 2022 | $42.70M | -4.0% |
| 2021 | $44.49M | +490.0% |
| 2020 | $7.54M | +187.9% |
| 2019 | -$8.58M | -12.9% |
| 2018 | -$7.59M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.16M | +86.3% | -28.2% |
| June 30, 2025 | $18.33M | +1146.9% | -23.8% |
| March 31, 2025 | $24.05M | +817.2% | +158.4% |
| December 31, 2024 | $9.31M | +220.1% | +31.8% |
| September 30, 2024 | $7.06M | +6.1% | +503.4% |
| June 30, 2024 | -$1.75M | -108.4% | +47.8% |
| March 31, 2024 | -$3.35M | -116.7% | +56.7% |
| December 31, 2023 | -$7.75M | -127.4% | -216.4% |
- Annovis Bio, Inc. showed an increase of +81.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Annovis Bio, Inc.’s stockholders equity has grown by 321.9% (from -$7.59 million to $16.85 million).
- The most recent figure is from Annovis Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: